Fabrizio Citarella

机构：Università Campus Bio-Medico, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Campus Bio Medico University Hospital, Istituti di Ricovero e Cura a Carattere Scientifico · ORCID：0000-0003-3096-4452

发表论文 109 篇 · 总被引 1881 次 · h-index 24

代表论文

• Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma (2025 · Nature Communications · 被引 18)
• First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study (2025 · The Lancet Oncology · 被引 16)
• Advanced-stage ALK-positive non–small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database (2025 · Lung Cancer · 被引 4)
• TTF-1 Negativity Predicts Poor Outcomes in Advanced Non-Squamous NSCLC Also in the Immunotherapy Era: A Multicenter Cohort Study and Meta-Analysis (2025 · Cancers · 被引 4)
• APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer (2026 · npj Precision Oncology · 被引 2)
• Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial (2026 · The Lancet Oncology · 被引 1)